Profiel
Lasse Tapani Leino is the founder of BioCis Pharma Oy, which was founded in 2003.
He held the title of Chief Executive Officer from 2003 to 2011.
Dr. Leino is also the President & Chief Executive Officer of DelSiTech Oy, where he has been working since 2013.
In his former position, he was the Chief Operating Officer of Laurantis Pharma Oy from 2011 to 2013.
Actieve functies van Lasse Tapani Leino
| Bedrijven | Functie | Begin |
|---|---|---|
DelSiTech Oy
 DelSiTech Oy Pharmaceuticals: MajorHealth Technology DelSiTech Ltd develops therapeutic delivery technology and drug formulations. Its services include small molecule drug delivery, delivery solutions for biological macromolecus, virus vector delivery, manufacturing service, and analytical service. The company was founded by Harry Jalonen in 2001, and is headquartered in Turku, Finland. | Algemeen Directeur | 01-06-2013 |
Eerdere bekende functies van Lasse Tapani Leino
| Bedrijven | Functie | Einde |
|---|---|---|
Laurantis Pharma Oy
 Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Operationeel Directeur | 01-01-2013 |
BioCis Pharma Oy
 BioCis Pharma Oy Pharmaceuticals: MajorHealth Technology BioCis Pharma is a clinical stage drug development company with the business idea to design and develop novel pharmaceutical products based on its proprietary technology platform. BioCis Pharma is targeting unmet medical needs in substantial therapeutic markets including inflammation, allergy, and cancer. The first products are being developed for major medical indications in dermatology, ophthalmology, and urology. BioCis Pharma was founded in 2003 by Dr. Lasse Leino and Dr. Jarmo Laihia, two experienced research and development professionals with both industrial and scientific backgrounds. Since the start of its operation in December 2004, BioCis Pharma has shown exceptional ability to move product candidates forward in development programs, having now two high-potential products under clinical Phase I-II development. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
BioCis Pharma Oy
BioCis Pharma Oy Pharmaceuticals: MajorHealth Technology BioCis Pharma is a clinical stage drug development company with the business idea to design and develop novel pharmaceutical products based on its proprietary technology platform. BioCis Pharma is targeting unmet medical needs in substantial therapeutic markets including inflammation, allergy, and cancer. The first products are being developed for major medical indications in dermatology, ophthalmology, and urology. BioCis Pharma was founded in 2003 by Dr. Lasse Leino and Dr. Jarmo Laihia, two experienced research and development professionals with both industrial and scientific backgrounds. Since the start of its operation in December 2004, BioCis Pharma has shown exceptional ability to move product candidates forward in development programs, having now two high-potential products under clinical Phase I-II development. | Health Technology |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Laurantis Pharma Oy engages in the development of pharmaceutical products. The company was founded in July 2008 and is headquartered in Turku, Finland. | Health Technology |
DelSiTech Oy
DelSiTech Oy Pharmaceuticals: MajorHealth Technology DelSiTech Ltd develops therapeutic delivery technology and drug formulations. Its services include small molecule drug delivery, delivery solutions for biological macromolecus, virus vector delivery, manufacturing service, and analytical service. The company was founded by Harry Jalonen in 2001, and is headquartered in Turku, Finland. | Health Technology |
